Molecular signaling pathways and cancer pain in gastric cancer

doi:10.3760/cma.j.issn.1673-422X.2019.12.010

Abstract

Abstract: The molecular signaling pathways in gastric cancer, such as mitogen-activated protein kinase, phosphoinoinositide 3-kinase/protein kinase B, AMP-activated protein kinase, cyclooxygenase 2/nuclear factor-κB and Wnt/β-catenin pathways are closely related to the occurrence and development of cancer pain. To understand the expression and role of gastric cancer molecular signaling pathway in cancer pain is expected to provide a new idea for the treatment of cancer pain.

Key words: Stomach neoplasms, Cancer pain, Signaling pathway

Xing Ziyang, Sun Chunxia. Molecular signaling pathways and cancer pain in gastric cancer[J]. Journal of International Oncology, 2019, 46(12): 755-759.

References ［31］

［1］	Li ZY, HuYang Y, Yang YT, et al. Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats［J］. World J Gastroenterol, 2017, 23(34): 6220-6230. DOI: 10.3748/wjg.v23.i34.6220.
［2］	Ding CP, Guo YJ, Li HN, et al. Red nucleus interleukin-6 participates in the maintenance of neuropathic pain through JAK/STAT3 and ERK signaling pathways［J］. Exp Neurol, 2018, 300: 212-221. DOI: 10.1016/j.expneurol.2017.11.012.
［3］	王思思, 孙海榉, 杜俊英, 等. 外周神经元PKCε-TRPV1通路在痛转化中的作用及中间信号分子［J］. 中国疼痛医学杂志, 2018, 24(7): 528-532. DOI: 10.3969/j.issn.1006-9852.2018.07.010.
［4］	Sun W, Zhang L, Li R. Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor［J］. Neurosci lett, 2017, 646: 68-74. DOI: 10.1016/j.neulet.2016.12.047.
［5］	Li Q, Liu S, Li L, et al. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway［J］. Glia, 2019, 67(3): 438-451. DOI: 10.1002/glia.23552.
［6］	Guo YJ, Li HN, Ding CP, et al. Red nucleus interleukin-1β evokes tactile allodynia through activation of JAK/STAT3 and JNK signaling pathways［J］. J Neurosci Res, 2018, 96(12): 1847-1861. DOI: 10.1002/jnr.24324.
［7］	Wang C, Kong X, Zhu C, et al. Wu-tou decoction attenuates neuropathic pain via suppressing spinal astrocytic IL-1R1/TRAF6/JNK signaling［J］. Oncotarget, 2017, 8(54): 92864-92879. DOI: 10.18632/oncotarget.21638.
［8］	Oh SH, Yoon MH, Lim KJ, et al. Nefopam downregulates autophagy and c-Jun N-terminal kinase activity in the regulation of neuropathic pain development following spinal nerve ligation［J］. BMC Anesthesiol, 2018, 18(1): 97. DOI: 10.1186/s12871-018-0559-8.
［9］	Meng XW, Gao JL, Zuo JL, et al. Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain［J］. Neurosci Res, 2017, 125: 37-45. DOI: 10.1016/j.neures.2017.06.006.
［10］	Nasseri B, Zaringhalam J, Daniali S, et al. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways［J］. Int Immunopharmacol, 2019, 70: 225-234. DOI: 10.1016/j.intimp.2019.02.042.
［11］	曲玉娟. TRPV4-MAPK通路在大鼠背根神经节持续受压致神经病理性疼痛中的作用机制研究［D］. 济南: 山东大学, 2016.
［12］	Yang F, Sun W, Luo WJ, et al. SDF1-CXCR4 Signaling contributes to the transition from acute to chronic pain state［J］. Mol Neurobiol, 2017, 54(4): 2763-2775. DOI: 10.1007/s12035-016-9875-5.
［13］	Hu B, Xu G, Zhang X, et al. Paeoniflorin attenuates inflammatory pain by inhibiting microglial activation and Akt/NF-κB signaling in the central nervous system［J］. Cell Physiol Biochem, 2018, 47(2): 842-850. DOI: 10.1159/000490076.
［14］	王婷婷, 冷承浩, 郭昆鹏, 等. 槐果碱通过抑制PI3K/Akt/NFκB信号通路缓解完全弗氏佐剂致大鼠炎性痛作用机制［J］. 中药药理与临床, 2019, 35(1): 63-67. DOI: 10.13412/j.cnki.zyyl.2019.01.014.
［15］	Liu W, Lv Y, Ren F. PI3K/Akt pathway is required for spinal central sensitization in neuropathic pain［J］. Cell Mol Neurobiol, 2018, 38(3): 747-755. DOI: 10.1007/s10571-017-0541-x.
［16］	Jiang SP, Zhang ZD, Kang LM, et al. Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion［J］. Exp Neurol, 2016, 275 Pt 1: 11-16. DOI: 10.1016/j.expneurol.2015.11.001.
［17］	Dai WL, Liu XT, Bao YN, et al. Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner［J］. Exp Mol Med, 2018, 50(11): 148. DOI: 10.1038/s12276-018-0175-1.
［18］	Li W, Wong CC, Zhang X, et al. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis［J］. Oncogene, 2018, 37(50): 6383-6398. DOI: 10.1038/s41388-018-0402-1.
［19］	Yu Y, Hou L, Song H, et al. Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells［J］. Mol Cell Biochem, 2017, 424(1-2): 173-183. DOI: 10.1007/s11010-016-2853-4.
［20］	Price TJ, Das V, Dussor G. Adenosine monophosphate-activated protein kinase (AMPK) activators for the prevention, treatment and potential reversal of pathological pain［J］. Curr Drug Targets, 2016, 17(8): 908-920.
［21］	Xiang HC, Lin LX, Hu XF, et al. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression［J］. J Neuroinflammation, 2019, 16(1): 34. DOI: 10.1186/s12974-019-1411-x.
［22］	Bullón P, AlcocerGómez E, Carrión AM, et al. AMPK phosphorylation modulates pain by activation of NLRP3 inflammasome［J］. Antioxid Redox Signal, 2016, 24(3): 157-170. DOI: 10.1089/ars.2014.6120.
［23］	Maixner DW, Yan X, Gao M, et al. Adenosine monophosphate-activated protein kinase regulates interleukin-1β expression and glial glutamate transporter function in rodents with neuropathic pain［J］. Anesthesiology, 2015, 122(6): 1401-1413. DOI: 10.1097/aln.0000000000000619.
［24］	Qu J, Tao XY, Teng P, et al. Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation［J］. J Neuroinflammation, 2017, 14(1): 228. DOI: 10.1186/s12974-017-0997-0.
［25］	Zhang Y, Tao GJ, Hu L, et al. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord［J］. J Neuroinflammation, 2017, 14(1): 211. DOI: 10.1186/s12974-017-0983-6.
［26］	Asiedu MN, Han C, Dib-Hajj SD, et al. The AMPK activator A769662 blocks voltage-gated sodium channels: discovery of a novel pharmacophore with potential utility for analgesic development［J］. PLoS One, 2017, 12(1): e0169882. DOI: 10.1371/journal.pone.0169882.
［27］	Gui Y, Li A, Chen F, et al. Involvement of AMPK/SIRT1 pathway in anti-allodynic effect of troxerutin in CCI-induced neuropathic pain［J］. Eur J Pharmacol, 2015, 769: 234-241. DOI: 10.1016/j.ejphar.2015.11.023.
［28］	Gui Y, Chen L, Duan S, et al. Methyl cinnamate alleviated CCI-induced upregualtion of spinal AMPA receptors and pain hypersensitivity by targeting AMPK［J］. Eur J Pharmacol, 2018, 833: 183-189. DOI: 10.1016/j.ejphar.2018.05.033.
［29］	Lu L, Pan C, Chen L, et al. AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in rats［J］. J Mol Cell Biol, 2016, 9(2): 132-143. DOI: 10.1093/jmcb/mjw043.
［30］	Guo L, Yilamu D, Sun L, et al. Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancer［J］. Exp Ther Med, 2015, 10(4): 1423-1428. DOI: 10.3892/etm.2015.2657.
［31］	Zhao Y, Yang Z. Effect of Wnt signaling pathway on pathogenesis and intervention of neuropathic pain［J］. Exp Ther Med, 2015, 16(4): 3082-3088. DOI: 10.3892/etm.2018.6512.

[1]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[2]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[3]	Xie Shuping, Sun Yahong, Wang Chao. Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer [J]. Journal of International Oncology, 2024, 51(3): 157-165.
[4]	Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan. Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer [J]. Journal of International Oncology, 2024, 51(3): 175-180.
[5]	Shao Huifang, Wang Xuehong, Lu Yongfu. Mechanism of action and clinical significance of CST1 in the progression of gastric cancer [J]. Journal of International Oncology, 2023, 50(8): 489-492.
[6]	Zhu Siyu, Wang Xuehong, Li Wenqian, Liu Shu. Level of serum FABP1 and its relationship with Helicobacter pylori infection in patients with gastric cancer [J]. Journal of International Oncology, 2023, 50(6): 336-341.
[7]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[8]	Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen. Correlation between blood lipid level and gastric cancer [J]. Journal of International Oncology, 2023, 50(3): 183-185.
[9]	Fan Shanlin, Wang Pinxiu, Kong Fei, Zhou Yujie, Yuan Wenzhen. Progress in the study of predictors of tumor regression grade after neoadjuvant chemotherapy for gastric cancer [J]. Journal of International Oncology, 2023, 50(2): 112-116.
[10]	Yang Jun, Li Rong, Zeng Jianchang. Clinical efficacy of Compound Kushen Injection combined with SOX regimen in the treatment of elderly patients with advanced gastric cancer [J]. Journal of International Oncology, 2023, 50(2): 82-86.
[11]	Deng Lili, Duan Xingyu, Li Baozhong. Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma [J]. Journal of International Oncology, 2023, 50(12): 751-757.
[12]	Li Jiayi, Wang Yue, Shang Lanlan, Xu Xing, Zhao Yan. Practice and prospect of artificial intelligence in diagnosis and treatment of gastric cancer [J]. Journal of International Oncology, 2023, 50(11): 677-682.
[13]	Yu Xiaopeng, Feng Qingqing, Zhao Wenfei, Zhao Wenwen, Wei Hongmei. Application of targeted therapy combined with immune checkpoint inhibitors in the treatment of HER2 positive advanced gastric cancer [J]. Journal of International Oncology, 2023, 50(10): 631-635.
[14]	Hu Ru, Li Donglin, Yan Xuebing. Methyltransferase like protein 14 and tumor [J]. Journal of International Oncology, 2022, 49(8): 478-483.
[15]	Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali. Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer [J]. Journal of International Oncology, 2022, 49(5): 276-281.